Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -528.34%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -4.51%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -82.56%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 40.11%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -6.30%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -420.31%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -104.07%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -14.95%
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn 9.22%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.22%
Dec 31, 2025 -28.54%
Sep 30, 2025 68.68%
Jun 30, 2025 -150.87%
Mar 31, 2025 -203.56%
Dec 31, 2024 56.08%
Sep 30, 2024 -177.06%
Jun 30, 2024 173.28%
Mar 31, 2024 -178.13%
Dec 31, 2023 -351.49%
Sep 30, 2023 9.28%
Jun 30, 2023 -41.40%
Mar 31, 2023 161.15%
Dec 31, 2022 34.36%
Sep 30, 2022 7.92%
Jun 30, 2022 -114.56%
Mar 31, 2022 -56.48%
Dec 31, 2021 -14.01%
Sep 30, 2021 14.89%
Jun 30, 2021 27.21%
Mar 31, 2021 -24.90%
Dec 31, 2020 31.14%
Sep 30, 2020 -56.23%
Jun 30, 2020 -138.24%
Mar 31, 2020 -58.55%
Dec 31, 2019 27.27%
Sep 30, 2019 -40.47%
Jun 30, 2019 202.35%
Mar 31, 2019 99.71%
Dec 31, 2018 -211.94%
Sep 30, 2018 -7.08%
Jun 30, 2018 -191.53%
Mar 31, 2018 -22,789.91%
Dec 31, 2017 -122.53%
Sep 30, 2017 55.72%
Jun 30, 2017 59.81%
Mar 31, 2017 -211.22%
Dec 31, 2016 231.18%
Sep 30, 2016 18.74%
Jun 30, 2016 -6.20%
Mar 31, 2016 103.67%
Dec 31, 2015 94.50%
Sep 30, 2015 -38.38%
Jun 30, 2015 -16.90%
Mar 31, 2015 -3,207.10%
Dec 31, 2014 -2,600.66%
Sep 30, 2014 -138.01%
Jun 30, 2014 -74.39%
Mar 31, 2014 52.26%
Dec 31, 2013 34.38%
Sep 30, 2013 349.61%
Jun 30, 2013 64.29%
Mar 31, 2013 86.75%
Dec 31, 2012 6.68%
Sep 30, 2012 90.70%
Jun 30, 2012 -82.19%
Mar 31, 2012 -385.82%
Dec 31, 2011 40.73%
Sep 30, 2011 -13.16%